期刊文献+

大肠癌组织中的EphA2和Ki-67蛋白与患者手术预后的相关性研究

Correlation of EphA2 and Ki-67 proteins in colorectal cancer tissues with prognosis of patients
下载PDF
导出
摘要 目的探讨大肠癌组织中Eph受体酪氨酸激酶A2(Eph receptor tyrosine kinase A2,EphA2)、Ki-67蛋白在大肠癌组织中的表达与患者预后的相关性。方法选取2016年7至12月收治的行手术治疗的大肠癌患者115例,使用免疫组化法分别检测癌组织和癌旁组织中EphA2、Ki-67蛋白表达情况,分析两种蛋白表达与肿瘤大小、癌组织分化、Dukes分期、淋巴结转移的相关性,Kaplan-Meier曲线对比癌组织中EphA2、Ki-67蛋白表达与患者生存时间的关系。结果癌组织中EphA2表达率为89.57%,Ki-67表达率为66.96%,均显著高于癌旁组织的23.78%、29.57%;EphA2和Ki-67蛋白表达与癌组织分化程度、Dukes分期、淋巴结转移均密切相关(P<0.05);随访36个月,Kaplan-Meier曲线显示EphA2、Ki-67蛋白表达阴性患者生存率明显高于表达阳性(P<0.05),Cox分析显示EphA2、Ki-67均是影响大肠癌预后的独立危险因素(P<0.001)。结论EphA2、Ki-67蛋白高表达可能在大肠癌发病、进展中参与度较高,并且可以预测患者近中期预后状况。 Objective To investigate the correlation between the expression of Eph receptor tyrosine kinase A2(EphA2)and Ki-67 protein in colorectal cancer tissues and their prognosis.Methods From July to December 2016,115 patients with colorectal cancer undergoing surgery were treated with immunohistochem-istry(SP)to detect the expression of EphA2 and Ki-67 protein in cancer tissues and adjacent tissues.Correlation between the expression of these proteins and tumor size,cancer tissue differentiation,Dukes stage,and lymph node metastasis.Kaplan-Meier curve was used to compare the relationship between EphA2,Ki-67 protein expression and cancer survival time in cancer tissues.Results The expression rate of EphA2 in cancer tissues was 89.57%,and the expression rate of Ki-67 was 66.96%,which were significantly higher than 23.78%and 29.57%of adjacent tissues.[(χ^2=45.017,P<0.001),(χ^2=32.195,P<0.001)];EphA2 and Ki-67 protein expression are closely related to the degree of cancer tissue differentiation,Dukes stage,lymph node metastasis(P<0.05);KM curve showed that patients with negative EphA2,Ki-67 protein expression were followed up for 36 months Survival rate was significantly higher than positive expression(P<0.05).Cox analysis showed that EphA2 and Ki-67 were independent risk factors affecting the prognosis of colorectal cancer(P<0.001).Conclusions The high expression of EphA2 and Ki-67 protein may be involved in the onset and progres-sion of colorectal cancer,and can predict the prognosis of patients in the near to mid-term.
作者 王璐 徐大洲 吕胜祥 李守英 Wang Lu;Xu Dazhou;Lv Shengxiang;Li Shouying(First People's Hospital of Lianyungang City,Lianyungang 222061,Jiangsu,China)
出处 《消化肿瘤杂志(电子版)》 2020年第1期35-38,共4页 Journal of Digestive Oncology(Electronic Version)
基金 连云港市第一人民医院青年英才豪森基金资助项目(QNN1815)。
关键词 大肠癌 Eph受体酪氨酸激酶A2 KI-67 预后 Colorectal cancer Eph receptor tyrosine kinase A2 Ki-67 Prognosis
  • 相关文献

参考文献10

二级参考文献58

  • 1王刚平,周瑞玲,张作峰,张红,袁宗怀,梁粉花.多灶性乳头状甲状腺癌中Ki-67、Cyclin D1和Bcl-2的表达与转移复发的关系[J].中华临床医师杂志(电子版),2011,5(12):3518-3522. 被引量:6
  • 2许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 3Fei Ren,Wei-Qi Sheng,Xiang Du.CD133:A cancer stem cells marker, is used in colorectal cancers[J].World Journal of Gastroenterology,2013,19(17):2603-2611. 被引量:19
  • 4韩洪秋,刘彤,赵丽中,戚峰,王鹏志.国际新的TNM分期对分析结直肠癌预后的临床意义[J].中华医学杂志,2006,86(12):819-821. 被引量:13
  • 5Kaplan N, Fatima A,Peng H, et al. EphA2/Ephrin - A1 signaling complexes restrict corneal epithelial cell migration[J]. Invest Ophthalmol Vis, 2012,53 (2) :936 - 45.
  • 6Chua CW,Choo SP. Targeted therapy in hepatocel- lular carcinoma[J]. Int J Hepatol,2011:348297.
  • 7Yang P, Yuan W, He J, et al. Overexpression of E phA2, MMP- 9, and MVD- CD34 in hepatocellular carcinoma: Implications for tumor progres sion and prognosis[J]. Hepatol Res, 2009,39 (12) 1169 - 1177.
  • 8shikawa M, Miyahara R, Sonobe M, et al. Higher expression of EphA2 and ephrin- A1 is related to favorable clinicopathologieal features in pathologi- cal stage I non- small cell lung carcinoma[J]. Lung Cancer,2012,76(3) :431 - 438.
  • 9Han LP, Liu JF, Liu XR, et al. Expression and prognostic significance of EphA2 and EphrinA- 1 in ovarian serous carcinomas[J]. Sichuan Da Xue Xue Bao Yi Xue Ban,2011,42(2):179-184.
  • 10uan W, Chen Z, Chen Z, et al. Silencing of EphA2 inhibits invasion of human gastric cancer SGC- 7901 cells in vitro and in vivo [J]. Neoplasma, 2012,59(1) :105 - 113.

共引文献103

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部